Journal of Thrombosis and Thrombolysis

Papers
(The H4-Index of Journal of Thrombosis and Thrombolysis is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database54
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection40
Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery36
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team32
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry29
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians27
Management of bone marrow biopsy related bleeding risks: a retrospective observational study26
Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate25
Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors23
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding21
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison21
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series21
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy19
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes19
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients17
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies16
0.14244079589844